Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page
- Check6 days agoChange DetectedA new revision label (v3.5.5) replaces the previous v3.5.4 on the study page, indicating an update to the record's metadata.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, signaling a minor update to the site’s underlying tooling or documentation rather than to trial content.SummaryDifference0.1%

- Check35 days agoChange DetectedNew and removed dates indicate updates to the study record history, reflecting revisions to the registry timeline. This does not change the substantive aspects of the trial such as design, endpoints, or eligibility.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page’s footer “Revision” version was updated from v3.5.2 to v3.5.3, indicating a site software/content management update rather than a change to the study record.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision has been updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check85 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.